ArticleReproductive sciences (Thousand Oaks, Calif.)2025
Single-Cell Transcriptome and RNA Sequencing Reveal Immune-Related Markers of Preeclampsia.
Article in Reproductive sciences (Thousand Oaks, Calif.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Understanding Preeclampsia: Integrating Placental Dysfunction, Immune Dysregulation and microRNA-Mediated Epigenetic Regulation.International journal of molecular sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Preeclampsia is a leading cause of maternal and fetal mortality, posing a threat to the mother and fetus's lives, but its pathogenesis is not yet clear. This study aimed to find the key target genes regulating preeclampsia in the placental immune microenvironment through single-cell and RNA-sequencing. This study compared the immune microenvironment of the placenta in preeclamptic and non-preeclamptic samples. Gene Ontology Enrichment (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), pseudotime, and cell-cell communication techniques were utilized to analyze the association between immune cell function and the pathogenesis of preeclampsia. Specific transcription factor target genes of immune cells were obtained based on the Scenic package and intersections were taken with their differentially expressed genes (DEGs). Key differential genes analysis was performed on the intersected genes based on the GSE234729 and GSE25906 datasets to obtain differential target genes regulating preeclampsia in immune cells. A total of 10 cell types were annotated in the placenta. Among them, macrophages had the highest immune score, followed by monocytes. GO and KEGG results demonstrated that they might be involved in inflammatory response and vascular remodeling in preeclampsia. Macrophages in the placenta were reclustered and annotated to monocytes, macrophages, and Hofbauer cell subsets, of these, monocytes could differentiate into macrophages and Hofbauer cells. Of all the immune cell-regulated preeclampsia differential genes SLC9A9, SH2B3, SDC3, RCC2, F13A1, CCL2, and CBLB were consistently expressed in two transcriptome datasets, and all were highly expressed in macrophages. These findings suggested that macrophages were implicated in the aberrant immune and inflammatory response of the preeclamptic placenta and found its key target genes that regulate preeclampsia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.